![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole Hydrochloride
2. Arotinolol
3. Arotinolol, (+-)-isomer
4. S 596
5. S-596
1. 68377-91-3
2. Arotinolol Hcl
3. Arotinolol Hydrochloride [jan]
4. Arotinolol (hydrochloride)
5. 9doi1ht306
6. 2-thiophenecarboxamide, 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-, Monohydrochloride, (+-)-
7. 68377-91-3 (hcl)
8. 5-[2-[[3-(tert-butylamino)-2-hydroxypropyl]thio]thiazol-4-yl]thiophene-2-carboxamide Hydrochloride
9. 5-[2-[3-(tert-butylamino)-2-hydroxypropyl]sulfanyl-1,3-thiazol-4-yl]thiophene-2-carboxamide;hydrochloride
10. S 596
11. Unii-9doi1ht306
12. Almarl (tn)
13. Arotinololhydrochloride
14. Ncgc00181107-01
15. S-596
16. (+-)-2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole Hcl
17. Dsstox_cid_26849
18. Dsstox_rid_81958
19. Dsstox_gsid_46849
20. Schembl348620
21. Arotinolol Hydrochloride,(s)-
22. Chembl3185966
23. Dtxsid1046849
24. Arotinolol Hydrochloride (jp17)
25. Chebi:31239
26. Bcp06721
27. Bcp28628
28. Tox21_112721
29. Arotinolol Hydrochloride [mi]
30. Mfcd00941421
31. Arotinolol Hydrochloride [mart.]
32. Arotinolol Hydrochloride [who-dd]
33. As-76884
34. Arotinolol Hcl;(s)-arotinolol Hydrochloride
35. Cas-68377-91-3
36. Db-055145
37. Ft-0602864
38. D01830
39. F20661
40. 377a913
41. Q27272409
42. (+/-)-2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole Hcl
43. 2-thiophenecarboxamide, 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-, Monohydrochloride, (+/-)-
44. 5-(2-(3-(tert-butylamino)-2-hydroxypropylthio)thiazol-4-yl)thiophene-2-carboxamide Hydrochloride
Molecular Weight | 408.0 g/mol |
---|---|
Molecular Formula | C15H22ClN3O2S3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 8 |
Exact Mass | 407.0562682 g/mol |
Monoisotopic Mass | 407.0562682 g/mol |
Topological Polar Surface Area | 170 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 406 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)